A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡Alphonse E. Sirica(GTx (United States)), Jennifer L. DeWitt(Virginia Commonwealth University)HepatologyDecember 14, 200710.1002/hep.22088Cited by 83SaveCiteExport RISWatch citationsRelated PapersCelecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation|Hepatology|2004|120Preclinical Assessment of Simultaneous Targeting of Epidermal Growth Factor Receptor (ERBB1) and ERBB2 as a Strategy for Cholangiocarcinoma Therapy†,‡|Hepatology|2010|44Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model|American Journal Of Pathology|2017|22